IP Library Granted Patent US 10,456,429
Granted Patent B2
US 10,456,429 · App. 14/654,166 · Granted Oct 29, 2019

Use of probiotic micro-organisms as an agent that promotes the synthesis of melanin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,456,429
App. No.
14/654,166
Granted
Oct 29, 2019
Kind
B2
Abstract

The present invention relates to the topical use of Bifidobacterium longum subsp. longum CNCM I-2618, as a pro-pigmenting agent, in particular in the prevention and/or treatment of alterations of skin and/or hair color homogeneity and for creating a uniform complexion.

Claims (12)

1. A non-therapeutic cosmetic method which comprises topically administering to a subject at least one probiotic Bifidobacterium longum subsp. longum micro-organism strain registered on Jan. 29, 2001 with CNCM (Paris, France) under the number I-2618, as an agent inducing skin and/or hair pigmentation, for promoting melanin synthesis thereby homogenizing the color of the skin and/or hair of said subject, wherein said Bifidobacterium longum subsp. longum CNCM I-2618 strain is in at least partially inactivated form and is presented in the form of a cell extract or lysate containing cell fragments and metabolites.

2. The cosmetic method according to claim 1 , for preventing and/or treating an alteration of skin and/or hair color homogeneity.

3. The cosmetic method according to claim 2 , wherein the alteration of skin and/or hair color homogeneity is selected in the group consisting of canities, melasma, acne pigmentation after-effects, post-inflammatory pigmentation, depigmentation caused by burns or surgery and benign facial dyschromia.

4. The cosmetic method according to claim 1 , wherein said Bifidobacterium longum subsp. longum CNCM I-2618 strain is formulated in a cosmetic composition further comprising a cosmetically acceptable vehicle.

5. The cosmetic method according to claim 4 , wherein the cosmetic composition further comprises an additional cosmetic agent.

6. The cosmetic method according to claim 1 , wherein the Bifidobacterium longum subsp. longum CNCM I-2618 micro-organism is inactivated by heat treatment.

7. The cosmetic method according to claim 1 , which comprises topically administering to a subject of at least one probiotic Bifidobacterium longum subsp. longum micro-organism strain registered on Jan. 29, 2001 with CNCM (Paris, France) under the number I-2618, as an agent inducing skin pigmentation, for promoting melanin synthesis thereby homogenizing the color of the skin of said subject,

wherein said Bifidobacterium longum subsp. longum CNCM I-2618 strain is in at least partially inactivated form and is presented in the form of a cell extract or lysate containing cell fragments and metabolites.

8. A therapeutic method, for preventing and/or treating an alteration of skin and/or hair color homogeneity of pathological origin, comprising administering topically to a subject in need thereof an effective amount of a probiotic Bifidobacterium longum subsp. longum micro-organism strain registered on Jan. 29, 2001 with CNCM (Paris, France) under the number I-2618, as an agent inducing skin and/or hair pigmentation, for promoting melanin synthesis, wherein said Bifidobacterium longum subsp. longum CNCM I-2618 strain is in at least partially inactivated form and is presented in the form of a cell extract or lysate containing cell fragments and metabolites.

9. The method according to claim 8 , wherein said alteration of skin and/or hair color homogeneity is selected in the group consisting of actinic lentigo, meadow grass dermatitis and vitiligo.

10. The method according to claim 8 , wherein said strain is inactivated by heat treatment.

11. The method according to claim 8 , for preventing and/or treating an alteration of skin color homogeneity of pathological origin.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2019
From: BRETON, LIONEL; GUENICHE, AUDREY; ZUCCOLO, MICHELA; MERCENIER, ANNICK; PRIOULT, GUENOLE
To: NESTEC S.A.
Reel/Frame 049812/0972 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2015
From: BRETON, LIONEL; GUENICHE, AUDREY; ZUCCOLO, MICHELA; MERCENIER, ANNICK; PRIOULT, GUENOLEE
To: L'OREAL
Reel/Frame 037003/0045 →